About 18 results found for searched term "GLP-1R agonist" (0.121 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M30166 | GLP-1R Antagonist 1 | GLP Receptor |
| GLP-1R Antagonist 1 (compound 5d) is an orally active, CNS penetrant and non-competitive antagonist of glucagon-like peptide 1 receptor (GLP-1R), with an IC50 of 650 nM. | ||
| M55684 | GLP-1R agonist | Glucagon Receptor |
| GLP-1R agonist DMB; Compound 2 | ||
| GLP-1R agonist is a potent GLP-1R (glucagon-like peptide 1 receptor) agonist, with KB of 26.3 nM for the recombinant human receptor. GLP-1R agonists play a key role in lowering glycated hemoglobin levels. It improves glycemic control and maintenance of body weight. | ||
| M10311 | Danuglipron (PF-06882961) | GLP Receptor |
| PF06882961; Danuglipron | ||
| Danuglipron (PF-06882961) is a potent, orally bioavailable agonist of the glucagon-like peptide-1 receptor (GLP-1R) agonist. | ||
| M25390 | Dapiglutide | GLP Receptor |
| ZP7570 | ||
| Dapiglutide (ZP7570) is a long-acting glucagon-like peptide-1 receptor 1R (GLP-1R)/Glucagon-like peptide-2 receptor (GLP-2R) dual agonist. | ||
| M31216 | FC382K10W15 TFA | GLP Receptor |
| FC382K10W15 TFA is a glucagon analogue and GLP-1R/GCGR agonist. FC382K10W15 TFA can be used in type 2 diabetes research. | ||
| M31335 | Supaglutide | GLP Receptor |
| Supaglutide is a novel GLP-1 analog that is also a GLP-1R agonist. | ||
| M31369 | Beinaglutide TFA | GLP Receptor |
| Beinaglutide TFA is a recombinant human GLP-1 (rhGLP-1) peptide and a GLP-1R agonist that can be used in studies related to obesity and non-alcoholic steatohepatitis (NASH). | ||
| M40527 | HM15211 | Glucagon Receptor |
| Efocipegtrutide | ||
| HM15211 is a novel, long-acting GLP-1R/GCGR/GIPR triple agonist for studies related to non-alcoholic steatohepatitis (NASH). | ||
| M40577 | GX-G6 | GLP Receptor |
| GX-G6 is a GLP-1R agonist that can be used in studies related to type 2 diabetes. | ||
| M40578 | LY2428757 | GLP Receptor |
| LY2428757 is a GLP-1R agonist that can be used in studies related to type 2 diabetes. | ||
| M40580 | MEDI-4166 | GLP Receptor |
| MEDI-4166 is a novel GLP-1 analog of an anti-preprotein convertase chymotrypsin 9 (PCSK9) monoclonal antibody fused to GLP-1, as well as a GLP-1R agonist, which can be used in cardiovascular disease-related studies. | ||
| M40584 | TTP054 | GLP Receptor |
| TTP054 is a GLP-1R agonist that can be used in studies related to type 2 diabetes. | ||
| M40585 | TTP273 | GLP Receptor |
| TTP273 is a GLP-1R agonist that can be used in studies related to type 2 diabetes. | ||
| M40709 | GSBR-1290 | GLP Receptor |
| GSBR-1290 is a GLP-1R agonist that can be used in studies related to type 2 diabetes and obesity. | ||
| M40750 | AZD9550 | Glucagon Receptor |
| AZD9550 is a GLP-1R/GCGR dual agonist that may be used in studies related to non-alcoholic steatohepatitis (NASH). | ||
| M41826 | Mazdutide TFA | Glucagon Receptor |
| Mazdutide (IBI-362; LY-3305677) TFA is an glucagon-like peptide-1 (GLP-1R)/glucagon receptor GCGR co-agonist, and a long-acting synthetic oxyntomodulin analog. | ||
| M41829 | FC382K10W15 TFA | Glucagon Receptor |
| FC382K10W15 TFA is a glucagon analogue and GLP-1R/GCGR agonist. | ||
| M49443 | Maridebart cafraglutide | GLP Receptor |
| MariTide | ||
| Maridebart cafraglutide is a peptide-coupled compound (PDC), as well as a GIPR antagonist and a GLP-1R agonist, which can be used in studies related to type 2 diabetes. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
